Perception towards COVID-19 vaccine among staff of urban health centres of Gandhinagar municipal corporation
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20232368Keywords:
COVID-19, , COVID Vaccine, SARS-Cov 2, Vaccine hesitancy, UHCAbstract
Background: COVID-19, an infectious respiratory illness caused by SARS-Cov 2 spread across the world and declared as pandemic in 2019. With the successive trail of COVID vaccine, the attention was turned towards its distribution and uptake. Vaccine hesitancy was greatest threat to the mass vaccination drive, which was major barrier for achieving desired vaccination goal. The main objective is to understand the knowledge, attitude and practices towards COVID-19 vaccine among staff of urban health centres of Gandhinagar municipal corporation.
Methods: A cross-sectional study was conducted to assess the knowledge, attitude and practices towards COVID-19 vaccine among staff of four urban health centres using a purposive sampling. Quantitative data was collected using self-administered semi-structured questionnaire.
Results: Out of 182 participants, 76 percent have taken COVISHIELD vaccine, 4 percent COVAXIN and 20 percent have not taken any vaccine. Out of these 20 percent; 14 percent denotes vaccine hesitancy due to its doubtful efficacy and fear.
Conclusions: The staff of UHCs shown good and adequate knowledge towards COVID vaccines. However, the vaccine hesitancy was found among staff regardless of their education status.
References
Chowdhury DS, Oommen AM. Epidemiology of COVID-19. J Digest Endoscop. 2020;11(1):3-7.
WHO Coronavirus Disease (COVID-19). Available at: https://covid19.who.int/. Accessed on 9 March 2022.
India Coronavirus: Worldometer. Available at: https://www.worldometers.info/coronavirus/country/india/. Accessed on 9 March 2021.
Mtimkulu-Eyde L, Denholm J, Narain A, Fatima R, Sagili KD, Perumal R, et al. Mandatory COVID-19 Vaccination: Lessons from Tuberculosis and HIV. Health Human Rights. 2007;24(1):85-91.
Frequently asked questions for the management of health workers in response to covid-19. Available at: https://iris.paho.org/bitstream/handle/10665.2/52727/PAHOIMSHSSCOVID-19200033_eng.pdf? sequence=1&isAllowed=y. Accessed on 9 March 2022.
Serum Institute Of India - ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) - Covishield. Available at: https://www.seruminstitute.com/product_ covishield.php. Accessed on 9 March 2022.
Immunizations, Vaccines and Biologicals. WHO. Available at: https://www.who.int/immunization/ research/forums_and_initiatives/1_RButler_VH_Threat_Child_Health_gvirf16.pdf?ua=1. Accessed on 9 March 2022.
Marti M, de Cola M, MacDonald NE, Dumolard L, Duclos P. Assessments of global drivers of vaccine hesitancy in 2014-Looking beyond safety concerns. PLoS One. 2017;12(3):e0172310.
Bhartiya S, Sengupta M, Dutta S, Roy A, Chakrabarti S, Mukhopadhyay I. Knowledge, attitude and practice survey towards COVID-19 vaccination: A mediation analysis. Int J Health Plann Manage. 2022;37(4):2063-80.
Mesch GS, Schwirian KP. Vaccination hesitancy: fear, trust, and exposure expectancy of an Ebola outbreak. Heliyon. 2019;5(7):e02016.
Suresh PS, Thejaswini V, Rajan T. Factors associated with 2009 pandemic influenza A (H1N1) vaccination acceptance among university students from India during the post-pandemic phase. BMC Infect Dis. 2011;11:205.
